Health
Messenger RNA vaccines lower risk for asymptomatic infection, study finds – Healio
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world…
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world study results published in Clinical Infectious Diseases.
Even after one dose, the risk for asymptomatic infection was reduced by 79%, researchers reported. The two messenger RNA vaccines authorized for use in the United States are made by Pfizer-BioNTech and Moderna.
“As people are undergoing their routine care and they’re caring for…
-
Noosa News24 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets
-
Noosa News21 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoHow to get the most from potted citrus and when they’ll fruit
-
General23 hours agoPeter Dutton partially walks back public service work-from-home vow